The Hawai‘i Department of Health (DOH) Food and Drug Branch is alerting residents to a recall of ReBoost Nasal Spray from MediNatura New Mexico, Inc. Maui Now's recent report confirmed the recall was prompted by the detection of yeast/mold and microbial contamination, with Achromobacter found at levels exceeding acceptable standards. This poses a potential health risk to consumers across Hawaii and the nation.
The recalled product, distributed nationwide, was available in Hawaii through various retail channels, including online sales. The U.S. Food and Drug Administration (FDA) has also issued a recall notice, reinforcing the severity of the situation. The FDA's announcement states that the use of the contaminated product could lead to adverse health outcomes, specifically for immunocompromised individuals.
For Hawaii’s entrepreneurs, the recall underscores the importance of stringent quality control measures within the supply chain. Businesses, especially those in the health and wellness sector, should review their product sourcing and distribution protocols to prevent similar incidents. Furthermore, investors in health-related startups should assess the companies' adherence to safety regulations and quality assurance practices.
Consumers who have purchased ReBoost Nasal Spray should immediately discontinue its use. The DOH advises consumers to check the product and follow the recall instructions provided by the manufacturer or the point of purchase. The recall information, including the product's NDC and UPC codes, and lot number, is available on the Hawaii Department of Health website.
